NOBIVAC Canine 3-DAPv

Every dog is different –– big, small, active or social. Nobivac® provides the flexibility to tailor vaccine protocols to each dog’s unique lifestyle needs.

Approved for the vaccination of healthy dogs for the prevention of disease caused by canine distemper virus and canine parvovirus, and as an aid in the prevention of disease caused by canine adenovirus (both infectious canine hepatitis and infectious tracheobronchitis) for up to 3 years following initial and booster vaccinations. Recommended for use in healthy dogs 7 weeks of age or older.

• Nobivac® 3-DAPv is the ONLY USDA-approved label for 3-year protection against core infectious diseases, distemper, adenovirus, and parvovirus.1
• Protects against all known strains of canine parvovirus, including CPV-2c.2
• Stimulates an IgG response for canine parainfluenza.

Indications:

Approved for the vaccination of healthy dogs for the prevention of disease caused by canine distemper virus and canine parvovirus, and as an aid in the prevention of disease caused by canine adenovirus (both infectious canine hepatitis and infectious tracheobronchitis) for up to 3 years following initial and booster vaccinations. Recommended for use in healthy dogs 7 weeks of age or older.

NOBIVAC® CANINE 3-DAPv IS A SAFE CHOICE

• Can be safely administered to dogs as young as 7 weeks of age
• High-titer CPV and canine distemper virus strains proven safe for dogs as young as 4 weeks of age
• No injection site or vaccine-related reactions reported during challenge studies

ADMINISTRATION AND DOSAGE

• Initial 1 mL dose given by subcutaneous route to healthy dogs as early as 7 weeks of age
• 1 mL booster doses given every 3 to 4 weeks until 12 weeks of age
• Revaccination every 3 years with a single dose thereafter
• Available in a 25 x 1 mL dose presentation

Safety Data Sheet

Manufacturer Information/Label